TABLE 3.
Histologic GVHD in patients without clinical acute GVHD, stratified according to busulfan treatment*
| Histologic GHVD | ||
|---|---|---|
| GVHD (% of row) | No GVHD | |
| Busulfan | 10 (67%) | 5 |
| No Busulfan | 5 (50%) | 5 |
*
Autografts are excluded
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.